Literature DB >> 15258797

Are vigabatrin-associated visual field constrictions asymptomatic?

T Schmidt, K Rüther, B Schmitz.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15258797     DOI: 10.1007/s00415-004-0443-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

1.  Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings.

Authors:  N R Miller; M A Johnson; S R Paul; C A Girkin; J D Perry; M Endres; G L Krauss
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

2.  Characteristics of a unique visual field defect attributed to vigabatrin.

Authors:  J M Wild; C Martinez; G Reinshagen; G F Harding
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

3.  Outer retinal dysfunction in patients treated with vigabatrin.

Authors:  C F Arndt; P Derambure; S Defoort-Dhellemmes; J C Hache
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

4.  A controlled study comparing visual function in patients treated with vigabatrin and tiagabine.

Authors:  G L Krauss; M A Johnson; S Sheth; N R Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.